A PHASE II STUDY OF NEOADJUVANT ANTIANGIOGENIC THERAPY COMBINED WITH CAPECITABINE (C) AND RADIOTHERAPY (RT) IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER (LARC)

被引：0
|
作者：
Torino, F. [4 ]
Cascinu, S. [1 ]
Ciardiello, F. [2 ]
Ballestrero, A. [3 ]
Lencioni, M. [5 ]
Filipelli, G. [6 ]
Martignetti, A.
Granetto, C. [7 ]
Gasparini, G. [8 ]
Frustaci, S. [9 ]
机构：
[1] Univ Politecn Delle Marche, Clin Oncol Med, Rome, Italy
[2] Univ Naples Federico 2, Naples, Italy
[3] Univ Genoa, Genoa, Italy
[4] Aco San Filippo Neri, Med Oncol B, Rome, Italy
[5] Osped St Chiara, Pisa, Italy
[6] Osped San Francesco Paola, Paola, Italy
[7] Osped Santa Croce & Carle, Cuneo, Italy
[8] San Filippo Neri Hosp, Div Med Oncol, Rome, Italy
[9] Ctr Riferimento Oncol, I-33081 Aviano, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [11] RESULTS FROM THE PHASE II XERT STUDY: NEOADJUVANT CETUXIMAB, CAPECITABINE, AND RADIOTHERAPY (RT) IN LOCALLY ADVANCED RESECTABLE RECTAL CANCER
    Velenik, V.
    Ocvirk, J.
    Oblak, I
    Anderluh, F.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 109 - 109
  • [12] Phase I/II study of preoperative cetuximab, capecitabine and external beam radiotherapy in patients with locally advanced rectal cancer (LARC)
    Machiels, J.
    Coche, J.
    Scalliet, P.
    Van Cutsem, E.
    Roels, S.
    Canon, J.
    Coster, B.
    Kerger, J.
    Remouchamps, V.
    Haustermans, K.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 183 - 183
  • [13] PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
    Crane, Christopher H.
    Eng, Cathy
    Feig, Barry W.
    Das, Prajnan
    Skibber, John M.
    Chang, George J.
    Wolff, Robert A.
    Krishnan, Sunil
    Hamilton, Stanley
    Janjan, Nora A.
    Maru, Dipen M.
    Ellis, Lee M.
    Rodriguez-Bigas, Miguel A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 824 - 830
  • [14] A phase II study of capecitabine (CAP) and pre-operative radiation therapy (RT) in resectable, locally advanced rectal cancer (LARC).
    De Paoli, A
    Chiara, S
    Luppi, G
    Friso, ML
    Beretta, G
    Delprete, S
    Pasetto, L
    Frustaci, S
    Santantonio, M
    Corvò, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 255S - 255S
  • [15] Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study
    Pei-Long Sun
    Bing Li
    Qi-Fa Ye
    [J]. International Journal of Colorectal Disease, 2012, 27 : 1325 - 1332
  • [16] Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study
    Sun, Pei-Long
    Li, Bing
    Ye, Qi-Fa
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (10) : 1325 - 1332
  • [17] Intensified neoadjuvant chemoradiotherapy (CRT) with capecitabine and irinotecan in patients with locally advanced rectal cancer (LARC): A phase I/II study.
    Klautke, G
    Foitzik, T
    Ludwig, K
    Klar, EJM
    Fietkau, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 292S - 292S
  • [18] Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients with locally advanced, K-ras-mutated rectal cancer (LARC): A phase I/II trial (SAKK 41/08)
    Von Moos, Roger
    Koeberle, Dieter
    Winterhalder, Ralph C.
    Cathomas, Richard
    Inauen, Roman Ignaz
    Zwahlen, Daniel Rudolf
    Roth, Arnaud
    Helbling, Daniel
    Gautschi, Oliver
    Baertschi, Daniela
    Kuehne, Reto
    Von Briel, Thomas
    Grzesiczek, Anja
    Samaras, Panagiotis
    Kollar, Attila
    Klingbiel, Dirk
    Zaugg, Kathrin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [19] Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
    Glynne-Jones, R
    Sebag-Montefiore, D
    Samuel, L
    Falk, S
    Maughan, T
    McDonald, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 252S - 252S
  • [20] A Phase II Trial of Neoadjuvant Capecitabine Combined With Hyperfractionated Accelerated Radiation Therapy in Locally Advanced Rectal Cancer
    Marsh, Robert de W.
    George, Thomas J.
    Siddiqui, Tariq
    Mendenhall, William M.
    Zlotecki, Robert A.
    Grobmyer, Stephen
    Hochwald, Steven
    Chang, Myron
    Larson, Bradley
    King, Judy
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 251 - 256
12345